xCystence Bio
PrivateLast Round
Pre Seed
Mar 30, 2026
Total Funding Raised
$500,000
Company Overview
xCystence Bio is a biotechnology company developing targeted protein degraders to treat Autosomal Dominant Polycystic Kidney Disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
targeted protein degradationTPDADPKDautosomal dominant polycystic kidney diseaseAURKAAurora kinase Adrug discoverybiotech startupsmall molecule drugskidney disease therapeuticsprotein degraderprecision medicinepreclinical developmentbiotech spin-outdrug pipeline
Historical Pricing
Historical view of private secondary pricing and transaction trends.
xCystence Bio Comparables
Compare xCystence Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mironid | 79% | |
| Eli Lilly and Company | 70% | |
| Regulus Therapeutics Inc. | 66% | |
xCystence Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 30, 2026 | ||||
| Grant | Sep 4, 2025 | ||||
| Grant | May 30, 2023 |
xCystence Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
| BioCurate | Pre Seed |
| Monash Investment Holdings | Pre Seed |
| Uniseed | Pre Seed |
| Breakthrough Victoria | Pre Seed |
xCystence Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about xCystence Bio's valuation, stock price, and market status.